Mendel Money Management Amgen Inc Transaction History

Mendel Money Management

$211 Million
Q4 2024

A detailed history of Mendel Money Management transactions in Amgen Inc stock. As of the latest transaction made, Mendel Money Management holds 4,517 shares of AMGN stock, worth $1.34 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

4,517

Previous 4,537 0.44%

Holding current value

$1.34 Million

Previous $1.46 Million 19.44%

% of portfolio

0.56%

Previous 0.66%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$258.78 - $328.31 $5,175 - $6,566	-20 Reduced 0.44%	4,517 $1.18 Million
Q3 2024 Nov 07, 2024	SELL	$309.38 - $337.38 $77,345 - $84,345	-250 Reduced 5.22%	4,537 $1.46 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $14,188 - $17,242	54 Added 1.14%	4,787 $1.5 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $18,552 - $22,394	-69 Reduced 1.44%	4,733 $1.35 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $1.23 Million - $1.39 Million	4,802 New	4,802 $1.38 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $92,051 - $114,284	421 Added 9.38%	4,907 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $9,213 - $10,894	43 Added 0.97%	4,486 $995,000
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $54,641 - $66,598	242 Added 5.76%	4,443 $1.07 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $203,149 - $258,125	887 Added 26.77%	4,201 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $31,424 - $35,441	140 Added 4.41%	3,314 $747,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $19,379 - $21,566	84 Added 2.72%	3,174 $772,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $677,544 - $749,541	3,090 New	3,090 $747,000

Others Institutions Holding AMGN

# of Institutions

3,108

Shares Held

404M

Call Options Held

7.35M

Put Options Held

7.05M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Money Management, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Money Management with notifications on news.

Account

Mendel Money Management Amgen Inc Transaction History